OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
60
Results
Show all
Save search
Copy query
Show results for
Unknown
(52)
Proteomics
(3)
Genomics
(2)
Metabolomics
(2)
Genomic
(1)
Organisms
Homo sapiens
(2)
Repository
MassIVE
(3)
EGA
(2)
MetaboLights
(2)
dbGaP
(1)
Technology Type
Mass spectrometry
(2)
Instrument Platform
LTQ Orbitrap Velos
(3)
Gas Chromatography MS -
(1)
Liquid Chromatography MS -
(1)
Liquid Chromatography MS - positive - reverse phase
(1)
Publication Date
2017
(3)
2025
(2)
CHEBI ID
CHEBI:63550
(1)
CHEBI:37154
(1)
CHEBI:30916
(1)
CHEBI:17677
(1)
CHEBI:15713
(1)
CHEBI:17202
(1)
CHEBI:22653
(1)
CHEBI:14321
(1)
CHEBI:35391
(1)
CHEBI:17239
(1)
CHEBI:6650
(1)
CHEBI:17659
(1)
CHEBI:28300
(1)
CHEBI:15996
(1)
CHEBI:17552
(1)
CHEBI:15422
(1)
CHEBI:32816
(1)
CHEBI:16761
(1)
CHEBI:25523
(1)
CHEBI:26806
(1)
CHEBI:13389
(1)
CHEBI:30769
(1)
Metabolite Name
TG 54:1|TG 18:0_18:0_18:1
(1)
TG 54:0
(1)
TG 56:2|TG 18:0_18:1_20:1
(1)
TG O-51:1
(1)
TG 52:0|TG 16:0_18:0_18:0
(1)
TG 54:2|TG 18:0_18:1_18:1
(1)
TG 50:0
(1)
TG 53:2|TG 16:0_18:1_19:1
(1)
TG 54:3|TG 18:1_18:1_18:1
(1)
TG 52:2|TG 16:0_18:1_18:1
(1)
TG 50:1|TG 16:0_16:0_18:1
(1)
TG 56:5|TG 18:0_18:1_20:4
(1)
TG 53:3|TG 17:1_18:1_18:1
(1)
TG 51:2|TG 16:0_17:1_18:1
(1)
TG 54:4|TG 18:1_18:1_18:2
(1)
TG 52:3|TG 16:1_18:1_18:1
(1)
TG 50:2|TG 16:0_16:1_18:1
(1)
TG 53:4
(1)
TG 56:6|TG 16:0_18:1_22:5
(1)
TG 54:5|TG 16:0_18:1_20:4
(1)
TG 52:4|TG 16:1_18:1_18:2
(1)
TG 56:7|TG 16:0_18:1_22:6
(1)
TG 50:3|TG 16:1_16:1_18:1
(1)
TG 48:2|TG 14:0_16:1_18:1
(1)
TG 54:6|TG 14:0_18:1_22:5
(1)
TG 46:1|TG 14:0_16:0_16:1
(1)
TG 52:5|TG 14:0_16:0_22:5
(1)
TG 50:4|TG 14:0_18:2_18:2
(1)
TG 56:8|TG 16:1_18:1_22:6
(1)
TG 54:7|TG 14:0_18:1_22:6
(1)
Release Date
2023
(8)
2022
(8)
2024
(6)
2021
(6)
2018
(6)
2019
(4)
2016
(4)
2025
(2)
2020
(2)
2017
(2)
2015
(2)
2014
(2)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank.
Not available
S-EPMC4053088
|
biostudies-literature
Cite
Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry.
Not available
S-EPMC5916755
|
biostudies-literature
Cite
Data on chemical composition of alkaloids of
Plumula nelumbinis
and antioxidant activity from thirteen habitats in China.
Not available
S-EPMC6240636
|
biostudies-literature
Cite
Health Care Access and Cardiovascular Risk Factor Management Among Working-Age US Adults During the Pandemic.
Not available
S-EPMC10872901
|
biostudies-literature
Cite
Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations.
Not available
S-EPMC10210411
|
biostudies-literature
Cite
Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy.
Not available
S-EPMC11294545
|
biostudies-literature
Cite
Helping ourselves, helping others: the Young Women's Breast Cancer Study (YWS) - a multisite prospective cohort study to advance the understanding of breast cancer diagnosed in women aged 40 years and younger.
Not available
S-EPMC11218027
|
biostudies-literature
Cite
Psychosocial issues and quality of life of parenting partners of young women with breast cancer.
Not available
S-EPMC9701537
|
biostudies-literature
Cite
Fertility concerns and treatment decision-making among national sample of young women with breast cancer.
Not available
S-EPMC10807590
|
biostudies-literature
Cite
Genetic variation in the vitamin D related pathway and breast cancer risk in women of African ancestry in the root consortium.
Not available
S-EPMC5755399
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets